Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Blast vacuolization in AML patients indicates adverse-risk AML and is associated with impaired survival after intensive induction chemotherapy.

Ballo O, Stratmann J, Serve H, Steffen B, Finkelmeier F, Brandts C.

PLoS One. 2019 Sep 30;14(9):e0223013. doi: 10.1371/journal.pone.0223013. eCollection 2019.

2.

Serum sphingolipids predict de novo hepatocellular carcinoma in hepatitis C cirrhotic patients with sustained virologic response.

Mücke VT, Thomas D, Mücke MM, Waidmann O, Zeuzem S, Sarrazin C, Pfeilschifter J, Vermehren J, Finkelmeier F, Grammatikos G.

Liver Int. 2019 Jun 17. doi: 10.1111/liv.14178. [Epub ahead of print]

PMID:
31207039
3.

Performance of Three Common Hepatitis C Virus (HCV) Genotyping Assays for Identification of HCV Genotype 2/1 Chimeras.

Peiffer KH, Kuhnhenn L, Stelzl E, Dietz J, Susser S, Tal AO, Finkelmeier F, Zuckerman E, Cornberg M, Barak M, Piazzolla V, Mangia A, Zeuzem S, Kessler HH, Vermehren J, Sarrazin C.

J Clin Microbiol. 2019 Jun 25;57(7). pii: e00060-19. doi: 10.1128/JCM.00060-19. Print 2019 Jul.

PMID:
31043467
4.

Tolerizing CTL by Sustained Hepatic PD-L1 Expression Provides a New Therapy Approach in Mouse Sepsis.

von Knethen A, Schäfer A, Kuchler L, Knape T, Christen U, Hintermann E, Fißlthaler B, Schröder K, Brandes RP, Genz B, Abshagen K, Pützer BM, Sha LK, Weigert A, Syed SN, Schulz M, Shah AM, Ernst A, Putyrski M, Finkelmeier F, Pesic M, Greten F, Hogardt M, Kempf VAJ, Gunne S, Parnham MJ, Brüne B.

Theranostics. 2019 Mar 16;9(7):2003-2016. doi: 10.7150/thno.28057. eCollection 2019.

5.

Programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort.

Scheiner B, Kirstein MM, Hucke F, Finkelmeier F, Schulze K, von Felden J, Koch S, Schwabl P, Hinrichs JB, Waneck F, Waidmann O, Reiberger T, Müller C, Sieghart W, Trauner M, Weinmann A, Wege H, Trojan J, Peck-Radosavljevic M, Vogel A, Pinter M.

Aliment Pharmacol Ther. 2019 May;49(10):1323-1333. doi: 10.1111/apt.15245. Epub 2019 Apr 12.

6.

Colonization with multidrug resistant organisms determines the clinical course of patients with acute myeloid leukemia undergoing intensive induction chemotherapy.

Ballo O, Tarazzit I, Stratmann J, Reinheimer C, Hogardt M, Wichelhaus TA, Kempf V, Serve H, Finkelmeier F, Brandts C.

PLoS One. 2019 Jan 23;14(1):e0210991. doi: 10.1371/journal.pone.0210991. eCollection 2019.

7.

Correction to: Myiasis in humans-a global case report evaluation and literature analysis.

Bernhardt V, Finkelmeier F, Verhoff MA, Amendt J.

Parasitol Res. 2019 Feb;118(2):723. doi: 10.1007/s00436-018-6187-x.

PMID:
30610364
8.

Myiasis in humans-a global case report evaluation and literature analysis.

Bernhardt V, Finkelmeier F, Verhoff MA, Amendt J.

Parasitol Res. 2019 Feb;118(2):389-397. doi: 10.1007/s00436-018-6145-7. Epub 2018 Nov 19. Erratum in: Parasitol Res. 2019 Jan 4;:.

PMID:
30456490
9.

Feasibility and safety of nivolumab in advanced hepatocellular carcinoma: real-life experience from three German centers.

Finkelmeier F, Czauderna C, Perkhofer L, Ettrich TJ, Trojan J, Weinmann A, Marquardt JU, Vermehren J, Waidmann O.

J Cancer Res Clin Oncol. 2019 Jan;145(1):253-259. doi: 10.1007/s00432-018-2780-8. Epub 2018 Oct 29.

PMID:
30374657
10.

Nivolumab for the treatment of hepatocellular carcinoma.

Finkelmeier F, Waidmann O, Trojan J.

Expert Rev Anticancer Ther. 2018 Dec;18(12):1169-1175. doi: 10.1080/14737140.2018.1535315. Epub 2018 Oct 22. Review.

PMID:
30304963
11.

Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosis.

Finkelmeier F, Canli Ö, Peiffer KH, Walter D, Tal A, Koch C, Pession U, Vermehren J, Trojan J, Zeuzem S, Piiper A, Greten FR, Grammatikos G, Waidmann O.

PLoS One. 2018 Jul 16;13(7):e0200855. doi: 10.1371/journal.pone.0200855. eCollection 2018.

12.

Risk of de novo Hepatocellular Carcinoma after HCV Treatment with Direct-Acting Antivirals.

Finkelmeier F, Dultz G, Peiffer KH, Kronenberger B, Krauss F, Zeuzem S, Sarrazin C, Vermehren J, Waidmann O.

Liver Cancer. 2018 May;7(2):190-204. doi: 10.1159/000486812. Epub 2018 Mar 1.

13.

Impact of HBV genotype and mutations on HBV DNA and qHBsAg levels in patients with HBeAg-negative chronic HBV infection.

Kuhnhenn L, Jiang B, Kubesch A, Vermehren J, Knop V, Susser S, Dietz J, Carra G, Finkelmeier F, Grammatikos G, Zeuzem S, Sarrazin C, Hildt E, Peiffer KH.

Aliment Pharmacol Ther. 2018 Jun;47(11):1523-1535. doi: 10.1111/apt.14636. Epub 2018 Apr 10.

PMID:
29637585
14.

Interferon-free treatment choice according to baseline RASs leads to high SVR rates in HCV genotype 1 infected patients.

Peiffer KH, Vermehren J, Kuhnhenn L, Susser S, Dietz J, Finkelmeier F, Weiler N, Welzel T, Grammatikos G, Zeuzem S, Sarrazin C.

J Infect Chemother. 2018 Jul;24(7):524-530. doi: 10.1016/j.jiac.2018.02.008. Epub 2018 Apr 5.

PMID:
29628383
15.

Divergent preS Sequences in Virion-Associated Hepatitis B Virus Genomes and Subviral HBV Surface Antigen Particles From HBV e Antigen-Negative Patients.

Peiffer KH, Kuhnhenn L, Jiang B, Mondorf A, Vermehren J, Knop V, Susser S, Walter D, Dietz J, Carra G, Finkelmeier F, Zeuzem S, Sarrazin C, Hildt E.

J Infect Dis. 2018 Jun 5;218(1):114-123. doi: 10.1093/infdis/jiy119.

PMID:
29528436
16.

Incidence, Risk Factors, and Outcome of Acute Kidney Injury in Neurocritical Care.

Büttner S, Stadler A, Mayer C, Patyna S, Betz C, Senft C, Geiger H, Jung O, Finkelmeier F.

J Intensive Care Med. 2018 Jan 1:885066617748596. doi: 10.1177/0885066617748596. [Epub ahead of print]

PMID:
29378487
17.

Myeloid Cell-Derived Reactive Oxygen Species Induce Epithelial Mutagenesis.

Canli Ö, Nicolas AM, Gupta J, Finkelmeier F, Goncharova O, Pesic M, Neumann T, Horst D, Löwer M, Sahin U, Greten FR.

Cancer Cell. 2017 Dec 11;32(6):869-883.e5. doi: 10.1016/j.ccell.2017.11.004.

18.

Multispecies blow fly myiasis combined with hypothermia in a man assumed to be dead.

Bernhardt V, Finkelmeier F, Tal A, Bojunga J, Derwich W, Meier S, Lux C, Verhoff MA, Amendt J.

Parasitol Res. 2018 Feb;117(2):579-583. doi: 10.1007/s00436-017-5691-8. Epub 2017 Nov 23.

PMID:
29170873
19.

Predictive Value of Computed Tomography Scans and Clinical Findings for the Need of Endoscopic Necrosectomy in Walled-off Necrosis From Pancreatitis.

Finkelmeier F, Sturm C, Friedrich-Rust M, Bojunga J, Sarrazin C, Tal A, Hausmann J, Zeuzem S, Zangos S, Albert J, Farnik H.

Pancreas. 2017 Sep;46(8):1039-1045. doi: 10.1097/MPA.0000000000000881.

PMID:
28796138
20.

Diagnostic Yield and Outcomes of Computed Tomography of the Head in Critically Ill Nontrauma Patients.

Finkelmeier F, Walter S, Peiffer KH, Cremer A, Tal A, Vogl T, Zeuzem S, Fichtlscherer S, Friedrich-Rust M, Bojunga J, Farnik H.

J Intensive Care Med. 2017 Jan 1:885066617720901. doi: 10.1177/0885066617720901. [Epub ahead of print]

PMID:
28718341
21.

Multiple plastic stents versus covered metal stent for treatment of anastomotic biliary strictures after liver transplantation: a prospective, randomized, multicenter trial.

Tal AO, Finkelmeier F, Filmann N, Kylänpää L, Udd M, Parzanese I, Cantù P, Dechêne A, Penndorf V, Schnitzbauer A, Friedrich-Rust M, Zeuzem S, Albert JG.

Gastrointest Endosc. 2017 Dec;86(6):1038-1045. doi: 10.1016/j.gie.2017.03.009. Epub 2017 Mar 14.

PMID:
28302527
22.

Application of Hemoadsorption in a Case of Liver Cirrhosis and Alcohol-Related Steatohepatitis with Preexisting Hepatitis C Infection.

Büttner S, Patyna S, Koch B, Finkelmeier F, Geiger H, Sarrazin C, Farnik H.

Blood Purif. 2017;44(1):30-31. doi: 10.1159/000455064. Epub 2017 Feb 25. No abstract available.

23.

Hypoxia Causes Downregulation of Dicer in Hepatocellular Carcinoma, Which Is Required for Upregulation of Hypoxia-Inducible Factor 1α and Epithelial-Mesenchymal Transition.

Ibrahim AA, Schmithals C, Kowarz E, Köberle V, Kakoschky B, Pleli T, Kollmar O, Nitsch S, Waidmann O, Finkelmeier F, Zeuzem S, Korf HW, Schmid T, Weigert A, Kronenberger B, Marschalek R, Piiper A.

Clin Cancer Res. 2017 Jul 15;23(14):3896-3905. doi: 10.1158/1078-0432.CCR-16-1762. Epub 2017 Feb 6.

24.

Reply to the Letter to the Editor concerning 'High levels of the soluble programmed death-ligand identify hepatocellular carcinoma patients with a poor prognosis'.

Finkelmeier F, Waidmann O.

Eur J Cancer. 2017 Jan;71:119-120. doi: 10.1016/j.ejca.2016.10.027. Epub 2016 Dec 15. No abstract available.

PMID:
27989635
25.

EphrinB2 repression through ZEB2 mediates tumour invasion and anti-angiogenic resistance.

Depner C, Zum Buttel H, Böğürcü N, Cuesta AM, Aburto MR, Seidel S, Finkelmeier F, Foss F, Hofmann J, Kaulich K, Barbus S, Segarra M, Reifenberger G, Garvalov BK, Acker T, Acker-Palmer A.

Nat Commun. 2016 Jul 29;7:12329. doi: 10.1038/ncomms12329.

26.

Response.

Finkelmeier F, Albert JG.

Gastrointest Endosc. 2016 Jun;83(6):1308. doi: 10.1016/j.gie.2016.02.011. No abstract available.

PMID:
27206603
27.

High levels of the soluble programmed death-ligand (sPD-L1) identify hepatocellular carcinoma patients with a poor prognosis.

Finkelmeier F, Canli Ö, Tal A, Pleli T, Trojan J, Schmidt M, Kronenberger B, Zeuzem S, Piiper A, Greten FR, Waidmann O.

Eur J Cancer. 2016 May;59:152-159. doi: 10.1016/j.ejca.2016.03.002. Epub 2016 Mar 31.

PMID:
27039170
28.

Bevacizumab in Combination with Chemotherapy for Colorectal Brain Metastasis.

Finkelmeier F, You SJ, Waidmann O, Wolff R, Zeuzem S, Bähr O, Trojan J.

J Gastrointest Cancer. 2016 Mar;47(1):82-8. doi: 10.1007/s12029-015-9795-z.

PMID:
26714801
29.

Low 25-Hydroxyvitamin D Levels Are Associated with Infections and Mortality in Patients with Cirrhosis.

Finkelmeier F, Kronenberger B, Zeuzem S, Piiper A, Waidmann O.

PLoS One. 2015 Jun 29;10(6):e0132119. doi: 10.1371/journal.pone.0132119. eCollection 2015.

30.

ERCP in elderly patients: increased risk of sedation adverse events but low frequency of post-ERCP pancreatitis.

Finkelmeier F, Tal A, Ajouaou M, Filmann N, Zeuzem S, Waidmann O, Albert J.

Gastrointest Endosc. 2015 Dec;82(6):1051-9. doi: 10.1016/j.gie.2015.04.032. Epub 2015 Jun 16.

PMID:
26089104
31.

Endoscopic findings in patients with eosinophilic esophagitis.

Waidmann O, Finkelmeier F, Welker MW, Sprinzl K, Zeuzem S, Albert JG.

Z Gastroenterol. 2015 May;53(5):379-84. doi: 10.1055/s-0034-1385767. Epub 2015 May 12.

PMID:
25965984
32.

Identifying indications for percutaneous (PTC) vs. endoscopic ultrasound (EUS)- guided "rendezvous" procedure in biliary obstruction and incomplete endoscopic retrograde cholangiography (ERC).

Albert JG, Finkelmeier F, Friedrich-Rust M, Kronenberger B, Trojan J, Zeuzem S, Sarrazin C.

Z Gastroenterol. 2014 Oct;52(10):1157-63. doi: 10.1055/s-0034-1366629. Epub 2014 Oct 14.

PMID:
25313627
33.

Serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis--a prospective cohort study.

Pleli T, Martin D, Kronenberger B, Brunner F, Köberle V, Grammatikos G, Farnik H, Martinez Y, Finkelmeier F, Labocha S, Ferreirós N, Zeuzem S, Piiper A, Waidmann O.

PLoS One. 2014 Jul 25;9(7):e103532. doi: 10.1371/journal.pone.0103532. eCollection 2014.

34.

Commentary: vitamin D deficiency and liver cancer - cause, effect or myth? Authors' reply.

Finkelmeier F, Kronenberger B, Köberle V, Bojunga J, Zeuzem S, Trojan J, Piiper A, Waidmann O.

Aliment Pharmacol Ther. 2014 Jun;39(12):1429-30. doi: 10.1111/apt.12772. No abstract available.

35.

Severe 25-hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma - a prospective cohort study.

Finkelmeier F, Kronenberger B, Köberle V, Bojunga J, Zeuzem S, Trojan J, Piiper A, Waidmann O.

Aliment Pharmacol Ther. 2014 May;39(10):1204-12. doi: 10.1111/apt.12731. Epub 2014 Mar 29.

36.

Single measurement of hemoglobin predicts outcome of HCC patients.

Finkelmeier F, Bettinger D, Köberle V, Schultheiß M, Zeuzem S, Kronenberger B, Piiper A, Waidmann O.

Med Oncol. 2014 Jan;31(1):806. doi: 10.1007/s12032-013-0806-2. Epub 2013 Dec 11.

PMID:
24326985

Supplemental Content

Loading ...
Support Center